February 18, 2026 · Form 4 insider transaction
PYOTT DAVID E I bought 3,729 shares of Tarsus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.; The RSUs will vest in three equal annual installments on March 15th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service.